Fibroblast Derivation
Fibroblast Derivation - Related Videos
13:58
Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
0 Views •
Cited by 38 •
2015
Generation of induced pluripotent stem cells provides fascinating prospects for the derivation of autologous transplants. However, progression through a pluripotent state and laborious re-differentiation still hinders clinical translation. Here we describe the derivation of adult human fibroblasts and their direct conversion into induced neural progenitor cells and the subsequent differentiation into neural lineages.
02:38
Isolating Induced Neural Progenitor Cell Colonies Derived From Adult Human Fibroblasts
0 Views •
2025
This video demonstrates a technique for isolating induced neural progenitor cells (iNPCs) derived from adult human fibroblasts. It outlines the steps involved in isolating the iNPC colonies and culturing them in laminin-coated multi-well plate wells in the presence of suitable culture media that facilitate the continued proliferation and expansion of the iNPC population.
06:19
Skin Punch Biopsy Explant Culture for Derivation of Primary Human Fibroblasts
0 Views •
Cited by 163 •
2013
The fibroblast explant culture protocol from human skin punch biopsies is a technically robust and simple way to derive skin cells within 4-8 weeks for banking of about 15-20 million cells at a low passage number.
15:43
Experimental Generation of Carcinoma-Associated Fibroblasts (CAFs) from Human Mammary Fibroblasts
0 Views •
Cited by 25 •
2011
Carcinoma-associated fibroblasts (CAFs) rich in myofibroblasts present within the tumour stroma, play a major role in driving tumour progression. We developed a coimplantation tumour xengraft model for experimentally generating CAFs from human mammary fibroblasts. The protocol describes how to establish CAF myofibroblasts that acquire an ability to promote tumourigenesis.
09:50
Fibroblast Derived Human Engineered Connective Tissue for Screening Applications
0 Views •
Cited by 6 •
2021
Presented here is a protocol to generate engineered connective tissues for a parallel culture of 48 tissues in a multi-well plate with double poles, suitable for mechanistic studies, disease modeling, and screening applications. The protocol is compatible with fibroblasts from different organs and species and is exemplified here with human primary cardiac fibroblasts.
FAQs
The starting material determines whether fibroblasts are obtained by isolating cells from primary tissue or by reprogramming stem cells or other differentiated cell types. These routes provide different entry points into the process, but each must support mesenchymal identity, proliferation, and matrix-producing activity. Selecting an appropriate source helps align the derived cells with the intended medical research question.
Culture conditions guide precursor cells toward a stable fibroblast-like state by promoting mesenchymal identity, cell proliferation, and extracellular-matrix production. These conditions influence whether the resulting population develops the intended structural and functional characteristics. In practice, controlling this stage is essential for producing cells that can be compared reliably across experiments involving repair, fibrosis, or disease modeling.
Characterization should address both cell identity and functional behavior rather than relying only on successful cell production. Researchers confirm that the population shows the expected mesenchymal identity and matrix-producing activity, while also evaluating whether it behaves consistently in the planned model. This verification supports meaningful interpretation in studies of tissue structure, repair, and pathological remodeling.
Consistent production reduces variation between experimental cell preparations, making observations easier to compare across disease models, treatment studies, and tissue-engineering experiments. Reproducible populations can support repeated testing of cellular behavior and responses, which strengthens conclusions about wound healing, fibrosis, tissue repair, and tumor-associated stromal interactions. Consistency is therefore important for both experimental reliability and translational relevance.
Derived fibroblasts provide models for examining wound healing, fibrosis, and tissue repair, where extracellular-matrix production and connective-tissue support are central concerns. They also enable investigation of interactions between tumors and surrounding stroma. These applications allow researchers to study how fibroblast populations contribute to normal structural maintenance or disease-associated tissue changes.
In drug screening, consistent fibroblast populations can provide a cellular system for evaluating responses relevant to repair, fibrosis, or tumor-stroma biology. In tissue engineering, their matrix-producing activity and role in supporting tissue structure make them useful for investigating engineered tissue development. Disease modeling adds another application by connecting defined cell production with pathological processes.